Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines. Journal of Analytical Oncology, [S. l.], v. 15, p. 53–57, 2026. DOI: 10.30683/1927-7229.2026.15.06. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/956. Acesso em: 7 jun. 2026.